Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Regor Pharmaceuticals Inc.
Regor Pharmaceuticals Inc.
Cogent Biosciences, Inc.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Second Life Therapeutics
Universidade Federal de Pernambuco
Danatlas Pharmaceuticals Co., Ltd
NovaOnco Therapeutics Co., Ltd.
Sun Yat-sen University
Convalife (Shanghai) Co., Ltd.